Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -502.90x is 96% above its 1-year average of -14215.13x, near the high end of its 1-year range (-39635.39x–-502.90x).
As of the fiscal period ended Friday, March 31, 2023. 97.49% above its 12-month average of -20069.15x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -502.90x.
INTEREST COVERAGE RATIO
-502.90x
INTEREST COVERAGE RATIO AVG TTM
-20069.15x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+97.49%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-7788.69%
vs the sector median at left
Pasithea Therapeutics Corp.
Market Cap
$15.03M
Interest Coverage Ratio
-502.90x
TTM Avg
-20069.15x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.10M
Interest Coverage Ratio
N/A
TTM Avg
149.09x
3Y Avg
163.65x
5Y Avg
163.65x
Market Cap
$15.24M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.54M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.44M
Interest Coverage Ratio
-38.62x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.65M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.18M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $15.03M | -502.90x | -20069.15x | N/A | N/A |
| Jin Medical International Ltd. (ZJYL)vs › | $15.10M | N/A | 149.09x | 163.65x | 163.65x |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.54M | -1.98x | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | -38.62x | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.65M | -68.14x | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.18M | -18.73x | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.00M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.99M | -206.17x | N/A | N/A | N/A |
Interest Coverage
-502.9x
Debt/Equity
0.00
Current Ratio
26.25
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -502.90x |
| 2022-12-31 | -39635.39x |
| 2021-09-30 | -2507.09x |
